File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry

TitleRisk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry
Authors
Keywordsall-cause death
atrial fibrillation
beta blockers
COPD
heart failure
Issue Date2-Apr-2024
PublisherWiley
Citation
Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, 2024, v. 13, n. 7 How to Cite?
Abstract

Background

Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of adverse events in patients with atrial fibrillation (AF); however, few data are available on this topic in Asian populations.

Methods and Results

Prospective observational study conducted on patients with AF enrolled in the Asia‐Pacific Heart Rhythm Society (APHRS) AF Registry. The diagnosis of COPD was based on data reported in the case report form by the investigators. Cox‐regression models were used to assess the 1‐year risk of a primary composite outcome of all‐cause death, thromboembolic events, acute coronary syndrome, and heart failure. Analysis on single outcomes and cardiovascular death was also performed. Interaction analysis was used to assess the risk of composite outcome and all‐cause death in different subgroups. The study included 4094 patients with AF (mean±SD age 68.5±12 years, 34.6% female), of whom 112 (2.7%) had COPD. Patients with COPD showed a higher incidence of the primary composite outcome (25.1% versus 6.3%, P<0.001), all‐cause death (14.9% versus 2.6%, P<0.001), cardiovascular death (2.0% versus 0.6%, P<0.001), and heart failure (8.3% versus 6.0%, P<0.001). On multiple Cox‐regression analysis, COPD was associated with a higher risk of the primary composite outcome (hazard ratio [HR], 3.17 [95% CI, 2.05–4.90]), all‐cause death (HR, 3.59 [95% CI, 2.04–6.30]), and heart failure (HR, 3.32 [95% CI, 1.56–7.03]); no statistically significant differences were found for other outcomes. The association between COPD and mortality was significantly modified by the use of beta blockers (Pint=0.018).

Conclusions

In Asian patients with AF, COPD is associated with worse prognosis. In patients with AF and COPD, the use of beta blockers was associated with a lower mortality.


Persistent Identifierhttp://hdl.handle.net/10722/348592
ISSN
2023 Impact Factor: 5.0
2023 SCImago Journal Rankings: 2.126
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorBucci, Tommaso-
dc.contributor.authorRomiti, Giulio Francesco-
dc.contributor.authorShantsila, Alena-
dc.contributor.authorTeo, Wee‐Siong-
dc.contributor.authorPark, Hyung‐Wook-
dc.contributor.authorShimizu, Wataru-
dc.contributor.authorCorica, Bernadette-
dc.contributor.authorProietti, Marco-
dc.contributor.authorTse, Hung‐Fat-
dc.contributor.authorChao, Tze‐Fan-
dc.contributor.authorFrost, Frederick-
dc.contributor.authorLip, Gregory Y H-
dc.contributor.authorAsia‐Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators-
dc.date.accessioned2024-10-10T00:31:50Z-
dc.date.available2024-10-10T00:31:50Z-
dc.date.issued2024-04-02-
dc.identifier.citationJournal of the American Heart Association Cardiovascular and Cerebrovascular Disease, 2024, v. 13, n. 7-
dc.identifier.issn2047-9980-
dc.identifier.urihttp://hdl.handle.net/10722/348592-
dc.description.abstract<h3>Background</h3><p>Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of adverse events in patients with atrial fibrillation (AF); however, few data are available on this topic in Asian populations.</p><h3>Methods and Results</h3><p>Prospective observational study conducted on patients with AF enrolled in the Asia‐Pacific Heart Rhythm Society (APHRS) AF Registry. The diagnosis of COPD was based on data reported in the case report form by the investigators. Cox‐regression models were used to assess the 1‐year risk of a primary composite outcome of all‐cause death, thromboembolic events, acute coronary syndrome, and heart failure. Analysis on single outcomes and cardiovascular death was also performed. Interaction analysis was used to assess the risk of composite outcome and all‐cause death in different subgroups. The study included 4094 patients with AF (mean±SD age 68.5±12 years, 34.6% female), of whom 112 (2.7%) had COPD. Patients with COPD showed a higher incidence of the primary composite outcome (25.1% versus 6.3%, <em>P</em><0.001), all‐cause death (14.9% versus 2.6%, <em>P</em><0.001), cardiovascular death (2.0% versus 0.6%, <em>P</em><0.001), and heart failure (8.3% versus 6.0%, <em>P</em><0.001). On multiple Cox‐regression analysis, COPD was associated with a higher risk of the primary composite outcome (hazard ratio [HR], 3.17 [95% CI, 2.05–4.90]), all‐cause death (HR, 3.59 [95% CI, 2.04–6.30]), and heart failure (HR, 3.32 [95% CI, 1.56–7.03]); no statistically significant differences were found for other outcomes. The association between COPD and mortality was significantly modified by the use of beta blockers (<em>P</em><sub>int</sub>=0.018).</p><h3>Conclusions</h3><p>In Asian patients with AF, COPD is associated with worse prognosis. In patients with AF and COPD, the use of beta blockers was associated with a lower mortality.</p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofJournal of the American Heart Association Cardiovascular and Cerebrovascular Disease-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectall-cause death-
dc.subjectatrial fibrillation-
dc.subjectbeta blockers-
dc.subjectCOPD-
dc.subjectheart failure-
dc.titleRisk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry-
dc.typeArticle-
dc.identifier.doi10.1161/JAHA.123.032785-
dc.identifier.scopuseid_2-s2.0-85189744369-
dc.identifier.volume13-
dc.identifier.issue7-
dc.identifier.eissn2047-9980-
dc.identifier.isiWOS:001195183200030-
dc.identifier.issnl2047-9980-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats